Loading
Transoral robotic surgery removes early (T1 to T2) throat tumours through the mouth with a robot and 3D endoscope, avoiding splitting the jaw or a tracheostomy. In HPV-positive oropharyngeal cancer the pathology then guides how much radiation to add, but randomised trials found it no better than radiation for swallowing, and surgeon volume matters.
FDA-cleared 2009 for T1-T2 oropharyngeal tumours. Enables primary surgical management of HPV-positive oropharyngeal cancer with pathology-guided adjuvant de-escalation (ECOG 3311). ORATOR trials found comparable oncologic outcomes to radiation with different toxicity profiles (swallowing favoured radiation in ORATOR; ORATOR2 halted after surgical deaths). Selection and surgeon volume matter.
Da Vinci or Flex robot instruments and a 3D endoscope pass through a mouth retractor to resect the tumour with margins; neck dissection is done separately.
Query for this technology: (TITLE:"Transoral robotic surgery" OR ABSTRACT:"Transoral robotic surgery" OR TITLE:"TORS" OR ABSTRACT:"TORS") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Transoral robotic surgery (TORS), not a curated reading list.
Shares HPV-positive oropharyngeal cancer, Oropharyngeal cancer (tonsil and base of tongue), Head and neck squamous cell carcinoma.
Shares Head and neck reconstruction: the free flap, and what it gives back, Hypopharyngeal cancer, Oropharyngeal cancer (tonsil and base of tongue), Nasopharyngeal carcinoma.
Shares Intuitive Surgical, Surgery roadmap: radical operations → less surgery → no surgery when a drug has done the work, Robotic & minimally invasive surgery.
Shares Intuitive Surgical, Robotic & minimally invasive surgery.
Shares Hypopharyngeal cancer, Oropharyngeal cancer (tonsil and base of tongue), Head and neck squamous cell carcinoma.
Shares HPV-positive oropharyngeal cancer, Oropharyngeal cancer (tonsil and base of tongue), Head and neck squamous cell carcinoma.
Shares HPV-positive oropharyngeal cancer, Oropharyngeal cancer (tonsil and base of tongue).
Shares HPV-positive oropharyngeal cancer, Oropharyngeal cancer (tonsil and base of tongue), Head and neck squamous cell carcinoma.